Immunitybio Inc. share price logo

Immunitybio Inc. Share Price

NASDAQ: IBRX

Mid Cap

$10.31

-0.12

(-1.20%)

Live

as on

Immunitybio Inc. Stock Performance

as on March 4, 2026 at 6:12 am IST

  • Day's Low

    Day's High

    $9.80
    $10.58
    downward going graph

    4.95%

    Downside

    2.62%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.83
    $12.43
    downward going graph

    82.25%

    Downside

    20.56%

    Upside

    downward going graph

Immunitybio Inc. share price movements today

Previous Close
$10.44
Open
$10.00
Volume
20.9M
Day's Low - High
$9.80 - $10.58
52 Week Low - High
$1.83 - $12.43

Immunitybio Inc. Historical Returns

1 Month Return
+ 64.93 %
3 Month Return
+ 374.55 %
1 Year Return
+ 266.32 %
3 Year Return
+ 427.27 %
5 Year Return
0 %

Immunitybio Inc. Stock Fundamentals & Key Indicators

Check Immunitybio Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.6B

EPS (TTM)

-0.29

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.43

Industry PE ratio

8.581171171171171

PEG Ratio

0

EBITDA

-240.6M

Revenue (TTM)

113.3M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Immunitybio Inc. Stock Valuation

Track how Immunitybio Inc. P/E has moved over time to understand its valuation trends.

Immunitybio Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-34.68x)

March 31, 2021

Today (-4.43x)

March 3, 2026

Industry (8.58x)

March 3, 2026

Highest (-1.91x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: -4.43x

Immunitybio Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunitybio Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$9.6BNA-4.430.00%
BUY$126.2B133.18%32.4732.94%
BUY$44.2B125.24%142.888.45%
NA$35.1BNA621.555.37%
BUY$82.6B77.02%18.8331.41%

Stock Returns calculator for Immunitybio Inc. Stock including INR - Dollar returns

The Immunitybio Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Immunitybio Inc. investment value today

Current value as on today

₹3,67,259

Returns

₹2,67,259

(+267.26%)

Returns from Immunitybio Inc. Stock

₹2,61,754 (+261.75%)

Dollar Returns*

₹5,505 (+5.5%)

Analyst Recommendation on Immunitybio Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Immunitybio Inc.. Average target price of $13.5

Immunitybio Inc. Share Price Target

Get share price movements and forecasts by analysts on Immunitybio Inc..

What analysts predicted

23.63%UPSIDE

Target Price

$13.5

Current Price

$10.31

Analyzed by

8 Analysts

Target

$13.50

Immunitybio Inc. target price $13.5, a slight upside of 23.63% compared to current price of $10.31. According to 8 analysts rating.

Immunitybio Inc. Stock’s Investor Sentiment and Interest

Investment in Immunitybio Inc. Shares on INDmoney has dropped by -24.44% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-24.44% versus previous 30 day period

Search interest for Immunitybio Inc. Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:20% versus previous 30 day period

Immunitybio Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
1
6
7
16
26
32
38
Gross Profit
0
0
0
1
6
7
16
26
27
34
Operating Income
-80
-85
-95
-99
-80
-69
-64
-71
-55
-64
EBITDA
-56
-196
-97
-91
-41
-40
-97
-59
-35
-31
Interest Expense
35
32
37
39
40
14
28
28
27
27
Depreciation
4
4
4
4
4
4
3
3
3
3
Income Before Tax
-95
-233
-134
-134
-85
-59
-129
-92
-67
-62
Income Tax Expense
-4
0
0
-4
-
0
0
0
0
0
Net Income
-95
-233
-134
-134
-85
-59
-129
-92
-67
-61
Net Profit Margin
-116563.41%
-167907.91%
-335272.50%
-12852.34%
-1404.01%
-783.40%
-784.92%
-350.26%
-209.77%
-161.80%

Immunitybio Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
0
0
0
14
113
Gross Profit
0
0
3
-8
0
0
0
0
14
112
Operating Income
-124
-99
-98
-66
-220
-330
-351
-362
-344
-256
EBITDA
-117
-90
-86
-56
-204
-320
-351
-478
-264
-223
Interest Expense
0
0
0
5
9
14
47
86
131
112
Depreciation
-
-
-
14
12
14
18
19
17
15
Income Before Tax
-121
-96
-96
-65
-226
-349
-417
-583
-413
-351
Income Tax Expense
0
0
0
0
-1
0
0
0
0
0
Net Income
-120
-96
-96
-65
-221
-346
-416
-583
-413
-351
Net Profit Margin
-274565.91%
-214273.33%
-204736.17%
-152997.67%
-36669.59%
-37129.55%
-173569.58%
-93761.41%
-2804.77%
-310.18%

Immunitybio Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-233
-134
-134
-85
-59
-129
-92
-67
-61
Operating Cash Flow
-115
-106
-100
-98
-85
-85
-79
-68
-70
Investing Cash Flow
2
-35
-51
65
9
4
-16
-181
43
Financing Cash Flow
200
10
148
15
106
0
172
173
54
Change in Cash
87
-132
-2
-18
31
-82
76
-76
28

Immunitybio Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-96
-96
-160
-224
-346
-416
-583
-413
-351
Operating Cash Flow
-48
-63
-152
-171
-274
-337
-366
-391
-304
Investing Cash Flow
99
57
18
-19
-84
27
-30
-12
-149
Financing Cash Flow
-34
0
114
150
505
233
558
281
400
Change in Cash
15
-7
-19
-40
146
-76
160
-121
-54

Global Institutional Holdings in Immunitybio Inc.

Funds
Holdings
Bank of America Corp
0.93%
Vanguard Group Inc
3.19%
JPMorgan Chase & Co
0.21%
Millennium Management LLC
0.34%
Morgan Stanley - Brokerage Accounts
0.31%

Immunitybio Inc. News & Key Events

  • img

    Today's Timeline - 20 January

    Tue, 11:49 PM

    -

    ImmunityBio shares rise after FDA's constructive feedback on Anktiva's label expansion plans for bladder cancer therapy.

    Wed, 00:17 AM

    -

    ImmunityBio stock surges 20.44% after announcing plans to submit additional data to the FDA for Anktiva's application.

Insights on Immunitybio Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, IBRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -129.64M → -61.94M (in $), with an average increase of 28.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, IBRX stock has moved up by 64.9%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IBRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 8 quarters, 40.0K → 38.28M (in $), with an average increase of 46.3% per quarter

About Immunitybio Inc.

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer (‘nk’) and t cells, tumoricidal macrophages, and memory t cells.
OrganisationImmunitybio Inc.
Headquarters3530 John Hopkins Court, San Diego, CA, United States, 92121
IndustryHealthcare
CEOMr. Richard Gerald Adcock
E-voting on sharesClick here to vote

Key Management of Immunitybio Inc.

Name

Title

Mr. David C. Sachs

Chief Financial Officer

Dr. Enrique Diloné Ph.D., RAC

Chief Technology Officer

Dr. Leonard S. Sender M.D.

Chief Medical Officer of Liquid Tumors & Cell Therapy

Dr. Sandeep K. Reddy M.D.

Chief Medical Officer

Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.S., M.Sc.

Founder, Executive Chairman and Global Chief Scientific & Medical Officer

Mr. Richard Gerald Adcock

President, CEO & Director

Dr. Barry J. Simon M.D.

Chief Corporate Affairs Officer & Director

Ms. Regan J. Lauer

Chief Accounting Officer

Ms. Sarah Singleton

Chief Communications Officer & Head of Patient Advocacy

Ms. Emily Arison

Senior Vice President of Human Resources

FAQs

What is Immunitybio Inc. share price today?

Immunitybio Inc. share price today is $10.31 as on . Immunitybio Inc. share today touched a day high of $10.58 and a low of $9.8.

What is the 52 week high and 52 week low for Immunitybio Inc. share?

Immunitybio Inc. share touched a 52 week high of $12.43 on and a 52 week low of $1.83 on . Immunitybio Inc. stock price today i.e. is trending at $10.31,which is 17.06% down from its 52 week high and 463.39% up from its 52 week low.

What is Immunitybio Inc.'s market capitalisation today?

Immunitybio Inc. market capitalisation is $0.01T as on .

How to invest in Immunitybio Inc. Stock (IBRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunitybio Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunitybio Inc. Shares that will get you 0.1455 shares as per Immunitybio Inc. share price of $10.31 per share as on March 4, 2026 at 12:42 am IST.

What is the minimum amount required to buy Immunitybio Inc. Stock (IBRX) from India?

Indian investors can start investing in Immunitybio Inc. (IBRX) shares with as little as ₹92.074 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Immunitybio Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunitybio Inc. share’s latest price of $10.31 as on March 4, 2026 at 12:42 am IST, you will get 0.9699 shares of Immunitybio Inc.. Learn more about fractional shares .